CS Diagnostics Corp. (CSDX)

Market Cap	46.25M -52.2%
Revenue (ttm)	98.73K -21.7%
Net Income	19.39K
EPS	0.00
Shares Out	249.99M
PE Ratio	2,384.68
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,650
Average Volume	41,313
Open	0.1500
Previous Close	0.1500
Day's Range	0.1500 - 0.1899
52-Week Range	0.0360 - 0.5500
Beta	-23.92
RSI	43.42
Earnings Date	May 13, 2026

About CS Diagnostics

CS Diagnostics Corp. engages in designing, manufacturing, and selling of wellness and medical products in Germany and internationally. The company offers MEDUSA, proprietary surface disinfectant product; and CS-Protect Hydrogel, a tissue spacer gel for use in radiation therapy. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSDX